{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T04:16:58Z","timestamp":1772165818008,"version":"3.50.1"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,7]],"date-time":"2025-04-07T00:00:00Z","timestamp":1743984000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,4,7]],"date-time":"2025-04-07T00:00:00Z","timestamp":1743984000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"1\u00b73\u00b75 project for disciplines of excellence\u2013Clinical Research Incubation Project, West China Hospital, Sichuan University","award":["2022HXFH029"],"award-info":[{"award-number":["2022HXFH029"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Psychiatry"],"DOI":"10.1186\/s12888-025-06774-8","type":"journal-article","created":{"date-parts":[[2025,4,7]],"date-time":"2025-04-07T14:09:29Z","timestamp":1744034969000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Obsessive-compulsive disorder and temporal lobe porencephaly: a case report"],"prefix":"10.1186","volume":"25","author":[{"given":"Gaoju","family":"Deng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuan","family":"Cao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Changjian","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,4,7]]},"reference":[{"issue":"8","key":"6774_CR1","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1038\/ejhg.2012.20","volume":"20","author":"E Verbeek","year":"2012","unstructured":"Verbeek E, et al. COL4A2 mutation associated with familial porencephaly and small-vessel disease. Eur J Hum Genet. 2012;20(8):844\u201351.","journal-title":"Eur J Hum Genet"},{"key":"6774_CR2","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1016\/j.jad.2018.11.080","volume":"245","author":"X Yang","year":"2019","unstructured":"Yang X, et al. Intrinsic brain abnormalities in drug-naive patients with obsessive-compulsive disorder: a resting-state functional MRI study. J Affect Disord. 2019;245:861\u20138.","journal-title":"J Affect Disord"},{"issue":"5","key":"6774_CR3","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1016\/j.euroneuro.2015.12.005","volume":"26","author":"OA van den Heuvel","year":"2016","unstructured":"van den Heuvel OA, et al. Brain circuitry of compulsivity. Eur Neuropsychopharmacol. 2016;26(5):810\u201327.","journal-title":"Eur Neuropsychopharmacol"},{"issue":"6","key":"6774_CR4","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1111\/j.1468-1331.2011.03656.x","volume":"19","author":"DC Perry","year":"2012","unstructured":"Perry DC, et al. Voxel-based morphometry in patients with obsessive-compulsive behaviors in behavioral variant frontotemporal dementia. Eur J Neurol. 2012;19(6):911\u20137.","journal-title":"Eur J Neurol"},{"issue":"1","key":"6774_CR5","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1186\/s12888-023-04740-w","volume":"23","author":"Z Ding","year":"2023","unstructured":"Ding Z, et al. Decreased gray matter volume and dynamic functional alterations in medicine-free obsessive-compulsive disorder. BMC Psychiatry. 2023;23(1):289.","journal-title":"BMC Psychiatry"},{"issue":"5","key":"6774_CR6","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1176\/appi.ajp.2017.17050485","volume":"175","author":"PSW Boedhoe","year":"2018","unstructured":"Boedhoe PSW, et al. Cortical abnormalities associated with pediatric and adult obsessive-compulsive disorder: findings from the ENIGMA obsessive-compulsive disorder working group. Am J Psychiatry. 2018;175(5):453\u201362.","journal-title":"Am J Psychiatry"},{"key":"6774_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajp.2022.103431","volume":"81","author":"W Tang","year":"2023","unstructured":"Tang W, et al. Exploring structural and functional alterations in drug-na\u00efve obsessive-compulsive disorder patients: an ultrahigh field multimodal MRI study. Asian J Psychiatr. 2023;81: 103431.","journal-title":"Asian J Psychiatr"},{"key":"6774_CR8","doi-asserted-by":"publisher","first-page":"102034","DOI":"10.1016\/j.nicl.2019.102034","volume":"24","author":"F Jaspers-Fayer","year":"2019","unstructured":"Jaspers-Fayer F, et al. Neural correlates of symptom provocation in pediatric obsessive-compulsive disorder. Neuroimage Clin. 2019;24:102034.","journal-title":"Neuroimage Clin"},{"key":"6774_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.yebeh.2019.106640","volume":"102","author":"EE Kilicaslan","year":"2020","unstructured":"Kilicaslan EE, et al. Differences in obsessive-compulsive symptom dimensions between patients with epilepsy with obsessive-compulsive symptoms and patients with OCD. Epilepsy Behav. 2020;102: 106640.","journal-title":"Epilepsy Behav"},{"key":"6774_CR10","doi-asserted-by":"publisher","first-page":"106723","DOI":"10.1016\/j.yebeh.2019.106723","volume":"102","author":"SJ Kim","year":"2020","unstructured":"Kim SJ, et al. Factors associated with obsessive-compulsive symptoms in people with epilepsy. Epilepsy Behav. 2020;102:106723.","journal-title":"Epilepsy Behav"},{"issue":"4","key":"6774_CR11","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1016\/j.yebeh.2005.02.010","volume":"6","author":"V Barbieri","year":"2005","unstructured":"Barbieri V, et al. Association of temporal lobe epilepsy and obsessive-compulsive disorder in a patient successfully treated with right temporal lobectomy. Epilepsy Behav. 2005;6(4):617\u20139.","journal-title":"Epilepsy Behav"},{"issue":"4","key":"6774_CR12","doi-asserted-by":"publisher","first-page":"321","DOI":"10.4103\/aian.AIAN_399_17","volume":"21","author":"AS Shreedhara","year":"2018","unstructured":"Shreedhara AS, et al. Improvement in obsessive-compulsive disorder following right anterior temporal lobectomy and amygdalohippocampectomy in a patient with refractory temporal lobe epilepsy with right mesial temporal sclerosis. Ann Indian Acad Neurol. 2018;21(4):321\u20134.","journal-title":"Ann Indian Acad Neurol"},{"issue":"4","key":"6774_CR13","doi-asserted-by":"publisher","first-page":"e20160558","DOI":"10.1542\/peds.2016-0558","volume":"138","author":"A Leung","year":"2016","unstructured":"Leung A, et al. Pediatric obsessive-compulsive disorder exacerbation and obstructive hydrocephalus: a case report. Pediatrics. 2016;138(4):e20160558.","journal-title":"Pediatrics"},{"issue":"9","key":"6774_CR14","volume":"16","author":"T Gupta","year":"2024","unstructured":"Gupta T, et al. Porencephaly and psychosis: a rare case of neurological and psychiatric intersection. Cureus. 2024;16(9): e69486.","journal-title":"Cureus"},{"issue":"3","key":"6774_CR15","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1080\/13554794.2016.1186199","volume":"22","author":"R de Oliveira-Souza","year":"2016","unstructured":"de Oliveira-Souza R, et al. Right hemisphere dominance for language in a woman with schizophrenia and a porencephalic cyst of the left hemisphere. Neurocase. 2016;22(3):324\u201331.","journal-title":"Neurocase"},{"key":"6774_CR16","doi-asserted-by":"publisher","DOI":"10.1186\/1471-244X-10-19","volume":"10","author":"A Douzenis","year":"2010","unstructured":"Douzenis A, et al. Porencephaly and psychosis: a case report and review of the literature. BMC Psychiatry. 2010;10: 19.","journal-title":"BMC Psychiatry"},{"issue":"11","key":"6774_CR17","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1001\/archpsyc.1989.01810110048007","volume":"46","author":"WK Goodman","year":"1989","unstructured":"Goodman WK, et al. The yale-brown obsessive compulsive scale. I. Development, use, and reliability. Arch Gen Psychiatry. 1989;46(11):1006\u201311.","journal-title":"Arch Gen Psychiatry"},{"issue":"11","key":"6774_CR18","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1001\/archpsyc.1989.01810110054008","volume":"46","author":"WK Goodman","year":"1989","unstructured":"Goodman WK, et al. The yale-brown obsessive compulsive scale. II. Validity. Arch Gen Psychiatry. 1989;46(11):1012\u20136.","journal-title":"Arch Gen Psychiatry"},{"issue":"6","key":"6774_CR19","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1590\/1516-4446-2018-0126","volume":"41","author":"CC Zhang","year":"2019","unstructured":"Zhang CC, et al. Development and psychometric evaluation of the Mandarin Chinese version of the yale-brown obsessive-compulsive scale - second edition. Braz J Psychiatry. 2019;41(6):494\u20138.","journal-title":"Braz J Psychiatry"},{"issue":"8","key":"6774_CR20","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1093\/jnen\/nlab026","volume":"80","author":"S Brock","year":"2021","unstructured":"Brock S, et al. Novel variant in COL4A1 causes extensive prenatal intracranial hemorrhage and porencephaly. J Neuropathol Exp Neurol. 2021;80(8):807\u201310.","journal-title":"J Neuropathol Exp Neurol"},{"issue":"5","key":"6774_CR21","doi-asserted-by":"publisher","first-page":"586","DOI":"10.3390\/medicina58050586","volume":"58","author":"MG Puiu","year":"2022","unstructured":"Puiu MG, et al. Psychosis associated with acquired porencephaly-cause or incidental finding? Case report and review of literature. Medicina (Kaunas). 2022;58(5):586.","journal-title":"Medicina (Kaunas)"},{"issue":"11","key":"6774_CR22","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1016\/S1474-4422(09)70236-4","volume":"8","author":"ST Pendlebury","year":"2009","unstructured":"Pendlebury ST, Rothwell PM. Prevalence, incidence, and factors associated with pre-stroke and post-stroke dementia: a systematic review and meta-analysis. Lancet Neurol. 2009;8(11):1006\u201318.","journal-title":"Lancet Neurol"},{"issue":"3","key":"6774_CR23","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1016\/j.neubiorev.2008.10.001","volume":"33","author":"WX Ng","year":"2009","unstructured":"Ng WX, et al. Neurobiological evidence for thalamic, hippocampal and related glutamatergic abnormalities in bipolar disorder: a review and synthesis. Neurosci Biobehav Rev. 2009;33(3):336\u201354.","journal-title":"Neurosci Biobehav Rev"},{"issue":"Pt 4","key":"6774_CR24","first-page":"853","volume":"132","author":"OA van den Heuvel","year":"2009","unstructured":"van den Heuvel OA, et al. The major symptom dimensions of obsessive-compulsive disorder are mediated by partially distinct neural systems. Brain. 2009;132(Pt 4):853\u201368.","journal-title":"Brain"},{"issue":"9","key":"6774_CR25","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1016\/j.biopsych.2005.01.037","volume":"57","author":"FR Asbahr","year":"2005","unstructured":"Asbahr FR, et al. Obsessive-compulsive symptoms among patients with Sydenham chorea. Biol Psychiatry. 2005;57(9):1073\u20136.","journal-title":"Biol Psychiatry"},{"issue":"9","key":"6774_CR26","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1007\/s00701-004-0312-6","volume":"146","author":"S Thobois","year":"2004","unstructured":"Thobois S, et al. Obsessive-compulsive disorder after unilateral caudate nucleus bleeding. Acta Neurochir (Wien). 2004;146(9):1027\u201331; discussion 1031.","journal-title":"Acta Neurochir (Wien)"},{"issue":"4","key":"6774_CR27","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1080\/09540260310001606737","volume":"15","author":"MA Grados","year":"2003","unstructured":"Grados MA. Obsessive-compulsive disorder after traumatic brain injury. Int Rev Psychiatry. 2003;15(4):350\u20138.","journal-title":"Int Rev Psychiatry"},{"issue":"4","key":"6774_CR28","doi-asserted-by":"publisher","first-page":"363","DOI":"10.2190\/XENN-NNWT-7N2K-R26A","volume":"34","author":"BR Coetzer","year":"2004","unstructured":"Coetzer BR. Obsessive-compulsive disorder following brain injury: a review. Int J Psychiatry Med. 2004;34(4):363\u201377.","journal-title":"Int J Psychiatry Med"},{"issue":"2","key":"6774_CR29","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1002\/da.10024","volume":"15","author":"CN Carmin","year":"2002","unstructured":"Carmin CN, et al. Treatment of late-onset OCD following basal ganglia infarct. Depress Anxiety. 2002;15(2):87\u201390.","journal-title":"Depress Anxiety"},{"issue":"1","key":"6774_CR30","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/s40211-019-00327-8","volume":"34","author":"V Veliki\u0107","year":"2020","unstructured":"Veliki\u0107 V, Wippel A, Freidl M. Relapse of obsessive-compulsive disorder after cerebral venous sinus thrombosis: a case report. Neuropsychiatr. 2020;34(1):27\u20139.","journal-title":"Neuropsychiatr"},{"issue":"1","key":"6774_CR31","doi-asserted-by":"publisher","first-page":"125.e7","DOI":"10.1016\/j.genhosppsych.2013.09.002","volume":"36","author":"A Hegde","year":"2014","unstructured":"Hegde A, et al. Arachnoid cyst masquerades as late onset obsessive-compulsive disorder. Gen Hosp Psychiatry. 2014;36(1):125.e7-9.","journal-title":"Gen Hosp Psychiatry"},{"issue":"3","key":"6774_CR32","first-page":"463","volume":"37","author":"P Radziwi\u0142\u0142owicz","year":"2003","unstructured":"Radziwi\u0142\u0142owicz P, et al. [Obsessive-compulsive disorder in a patient with septum pellucidum cyst. Psychiatric and psychologic case study]. Psychiatr Pol. 2003;37(3):463\u201375.","journal-title":"Psychiatr Pol"},{"key":"6774_CR33","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.jad.2016.08.027","volume":"207","author":"J Fan","year":"2017","unstructured":"Fan J, et al. Spontaneous neural activity in the right superior temporal gyrus and left middle temporal gyrus is associated with insight level in obsessive-compulsive disorder. J Affect Disord. 2017;207:203\u201311.","journal-title":"J Affect Disord"},{"issue":"9","key":"6774_CR34","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0075273","volume":"8","author":"M Subir\u00e0","year":"2013","unstructured":"Subir\u00e0 M, et al. Brain structural alterations in obsessive-compulsive disorder patients with autogenous and reactive obsessions. PLoS One. 2013;8(9): e75273.","journal-title":"PLoS One"},{"issue":"5","key":"6774_CR35","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1002\/da.20171","volume":"23","author":"JS Choi","year":"2006","unstructured":"Choi JS, et al. Morphometric alterations of anterior superior temporal cortex in obsessive-compulsive disorder. Depress Anxiety. 2006;23(5):290\u20136.","journal-title":"Depress Anxiety"},{"issue":"1","key":"6774_CR36","doi-asserted-by":"publisher","first-page":"35","DOI":"10.7334\/psicothema2016.86","volume":"29","author":"OF Gon\u00e7alves","year":"2017","unstructured":"Gon\u00e7alves OF, et al. Alterations of gray and white matter morphology in obsessive compulsive disorder. Psicothema. 2017;29(1):35\u201342.","journal-title":"Psicothema"},{"issue":"8","key":"6774_CR37","doi-asserted-by":"publisher","DOI":"10.1038\/tp.2017.189","volume":"7","author":"PS Moreira","year":"2017","unstructured":"Moreira PS, et al. The neural correlates of obsessive-compulsive disorder: a multimodal perspective. Transl Psychiatry. 2017;7(8): e1224.","journal-title":"Transl Psychiatry"},{"key":"6774_CR38","doi-asserted-by":"publisher","DOI":"10.1016\/j.nicl.2023.103545","volume":"40","author":"Z Xu","year":"2023","unstructured":"Xu Z, et al. Altered brain functional network topology in obsessive-compulsive disorder: a comparison of patients with varying severity of depressive symptoms and the impact on psychosocial functioning. Neuroimage Clin. 2023;40: 103545.","journal-title":"Neuroimage Clin"},{"issue":"6","key":"6774_CR39","doi-asserted-by":"publisher","first-page":"2434","DOI":"10.1177\/0300060518807058","volume":"47","author":"PW Shan","year":"2019","unstructured":"Shan PW, et al. Aberrant functional connectivity density in patients with treatment-refractory obsessive-compulsive disorder: a pilot study. J Int Med Res. 2019;47(6):2434\u201345.","journal-title":"J Int Med Res"},{"issue":"2","key":"6774_CR40","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1016\/j.euroneuro.2015.12.008","volume":"26","author":"MGP Feenstra","year":"2016","unstructured":"Feenstra MGP, et al. Prazosin addition to fluvoxamine: a preclinical study and open clinical trial in OCD. Eur Neuropsychopharmacol. 2016;26(2):310\u20139.","journal-title":"Eur Neuropsychopharmacol"},{"issue":"3","key":"6774_CR41","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/0006-3223(91)90107-W","volume":"30","author":"LS Austin","year":"1991","unstructured":"Austin LS, et al. Dopamine blocking activity of clomipramine in patients with obsessive-compulsive disorder. Biol Psychiatry. 1991;30(3):225\u201332.","journal-title":"Biol Psychiatry"},{"issue":"8","key":"6774_CR42","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.4088\/JCP.v65n0803","volume":"65","author":"D Denys","year":"2004","unstructured":"Denys D, et al. A double-blind, randomized, placebo-controlled trial of quetiapine addition in patients with obsessive-compulsive disorder refractory to serotonin reuptake inhibitors. J Clin Psychiatry. 2004;65(8):1040\u20138.","journal-title":"J Clin Psychiatry"},{"issue":"8","key":"6774_CR43","doi-asserted-by":"publisher","first-page":"700","DOI":"10.4088\/JCP.v63n0807","volume":"63","author":"D Denys","year":"2002","unstructured":"Denys D, van Megen H, Westenberg H. Quetiapine addition to serotonin reuptake inhibitor treatment in patients with treatment-refractory obsessive-compulsive disorder: an open-label study. J Clin Psychiatry. 2002;63(8):700\u20133.","journal-title":"J Clin Psychiatry"},{"key":"6774_CR44","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/j.pnpbp.2018.12.009","volume":"90","author":"DD Zhou","year":"2019","unstructured":"Zhou DD, et al. Augmentation agents to serotonin reuptake inhibitors for treatment-resistant obsessive-compulsive disorder: a network meta-analysis. Prog Neuropsychopharmacol Biol Psychiatry. 2019;90:277\u201387.","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"issue":"2","key":"6774_CR45","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.rpsm.2019.01.003","volume":"12","author":"JM Menchon","year":"2019","unstructured":"Menchon JM, et al. Pharmacological treatment of obsessive compulsive disorder in adults: a clinical practice guideline based on the ADAPTE methodology. Rev Psiquiatr Salud Ment (Engl Ed). 2019;12(2):77\u201391.","journal-title":"Rev Psiquiatr Salud Ment (Engl Ed)"},{"key":"6774_CR46","unstructured":"National Collaborating Centre for Mental H, National Institute for Health and Care Excellence. Guidelines, in obsessive-compulsive disorder: core interventions in the treatment of obsessive-compulsive disorder and body dysmorphic disorder. Leicester: British Psychological Society (UK); 2006. Copyright \u00a9 2006, The British Psychological Society & The Royal College of Psychiatrists."},{"issue":"Suppl 1","key":"6774_CR47","first-page":"S51","volume":"61","author":"A Thamby","year":"2019","unstructured":"Thamby A, Jaisoorya TS. Antipsychotic augmentation in the treatment of obsessive-compulsive disorder. Indian J Psychiatry. 2019;61(Suppl 1):S51-s57.","journal-title":"Indian J Psychiatry"},{"issue":"3","key":"6774_CR48","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1007\/s11920-012-0268-9","volume":"14","author":"DJ Stein","year":"2012","unstructured":"Stein DJ, et al. A 2012 evidence-based algorithm for the pharmacotherapy for obsessive-compulsive disorder. Curr Psychiatry Rep. 2012;14(3):211\u20139.","journal-title":"Curr Psychiatry Rep"},{"key":"6774_CR49","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1186\/s12888-014-0317-5","volume":"14","author":"D Veale","year":"2014","unstructured":"Veale D, et al. Atypical antipsychotic augmentation in SSRI treatment refractory obsessive-compulsive disorder: a systematic review and meta-analysis. BMC Psychiatry. 2014;14:317.","journal-title":"BMC Psychiatry"},{"issue":"3","key":"6774_CR50","first-page":"231","volume":"1","author":"B Aouizerate","year":"2005","unstructured":"Aouizerate B, et al. Updated overview of the putative role of the serotoninergic system in obsessive-compulsive disorder. Neuropsychiatr Dis Treat. 2005;1(3):231\u201343.","journal-title":"Neuropsychiatr Dis Treat"},{"issue":"3\u20134","key":"6774_CR51","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1159\/000106474","volume":"55","author":"CH Kim","year":"2007","unstructured":"Kim CH, et al. Dopamine transporter density in the basal ganglia in obsessive-compulsive disorder, measured with [123I]IPT SPECT before and after treatment with serotonin reuptake inhibitors. Neuropsychobiology. 2007;55(3\u20134):156\u201362.","journal-title":"Neuropsychobiology"},{"issue":"3","key":"6774_CR52","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1016\/j.pharmthera.2011.09.006","volume":"132","author":"C Pittenger","year":"2011","unstructured":"Pittenger C, Bloch MH, Williams K. Glutamate abnormalities in obsessive compulsive disorder: neurobiology, pathophysiology, and treatment. Pharmacol Ther. 2011;132(3):314\u201332.","journal-title":"Pharmacol Ther"},{"issue":"1","key":"6774_CR53","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1038\/s41572-019-0102-3","volume":"5","author":"DJ Stein","year":"2019","unstructured":"Stein DJ, et al. Obsessive-compulsive disorder. Nat Rev Dis Primers. 2019;5(1):52.","journal-title":"Nat Rev Dis Primers"},{"issue":"9","key":"6774_CR54","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.1176\/appi.ajp.2007.06091479","volume":"164","author":"D Mamo","year":"2007","unstructured":"Mamo D, et al. Differential effects of aripiprazole on D(2), 5-HT(2), and 5-HT(1A) receptor occupancy in patients with schizophrenia: a triple tracer PET study. Am J Psychiatry. 2007;164(9):1411\u20137.","journal-title":"Am J Psychiatry"}],"container-title":["BMC Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12888-025-06774-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12888-025-06774-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12888-025-06774-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T12:56:05Z","timestamp":1744203365000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpsychiatry.biomedcentral.com\/articles\/10.1186\/s12888-025-06774-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,7]]},"references-count":54,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["6774"],"URL":"https:\/\/doi.org\/10.1186\/s12888-025-06774-8","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-5419626\/v1","asserted-by":"object"}]},"ISSN":["1471-244X"],"issn-type":[{"value":"1471-244X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,7]]},"assertion":[{"value":"9 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All the actions described in this case report were conducted in accordance with ethical guidelines. Informed consent was obtained from the patient for participation in this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Informed consent was obtained from the patient for the publication of anonymized information in this manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"341"}}